South State Corp Iovance Biotherapeutics, Inc. Transaction History
South State Corp
- $2.24 Billion
- Q2 2025
A detailed history of South State Corp transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, South State Corp holds 5,000 shares of IOVA stock, worth $11,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$11,050% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
286Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$64 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$55.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$46.9 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.1 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$21.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $349M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...